Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?

Marinoni, IlariaIlariaMarinoni2024-10-062024-10-062022-05https://boris-portal.unibe.ch/handle/20.500.12422/58163enneuroendocrine cells neuroendocrine tumors pancreatic endocrine tumour pancreatic islet cell500 - Science::570 - Life sciences; biology600 - Technology::610 - Medicine & healthPrognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?article10.48350/1620693397586910.1136/gutjnl-2021-324664